Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer

Clinical trial NCT03872505 · WITHDRAWN

Trial details

NCT number: NCT03872505
Sponsor: Cedars-Sinai Medical Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Triple Negative Breast Cancer

Start date: 2022-07-01
Primary completion: 2022-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.